Tag: Investing

Read More

Red Light Holland posts sales dip amid retail lull, ‘debanking’ issues

Red Light Holland (CSE: TRIP) (OTCQB: TRUFF) reported a 9.5% slide in third-quarter revenue Wednesday, as the Ontario-based psychedelics company faced challenges including lower mushroom sales and a returned Costco order. The company, which sells functional mushrooms, mushroom grow kits and legal psilocybin truffles, reported revenue of $1.17 million for …

Read More

Harmony Biosciences posts record sales for narcolepsy drug, maps synthetic CBD plans

Harmony Biosciences Holdings (Nasdaq: HRMY) reported record sales for its narcolepsy treatment WAKIX in 2024 and projected stronger revenue for 2025, as the company advances several clinical trials including a non-THC cannabidiol treatment for a rare genetic disorder. The company said Tuesday that WAKIX generated $201.3 million in revenue during …